This HTML5 document contains 35 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n12http://bio2rdf.org/drugbank:
n11http://linked.opendata.cz/resource/drugbank/drug/DB02816/identifier/pdb/
n13http://linked.opendata.cz/resource/drugbank/drug/DB02816/identifier/pubchem-compound/
admshttp://www.w3.org/ns/adms#
n9http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
n4http://linked.opendata.cz/resource/drugbank/drug/DB02816/identifier/pubchem-substance/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n10http://linked.opendata.cz/resource/drugbank/drug/DB02816/identifier/drugbank/
owlhttp://www.w3.org/2002/07/owl#
n5http://linked.opendata.cz/ontology/drugbank/
n6http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB02816
rdf:type
n5:Drug
n5:group
experimental
owl:sameAs
n9:DB02816 n12:DB02816
dcterms:title
7-(1-Methyl-1,2,3-Triazol-4-Yl)-6-Formyl-2,7-Dihydro-[1,4]Thiazepine-3-Carboxylic Acid, Brl42715, C6-(N1-Methyl-1,2,3-Triazolylmethylene)Penem
adms:identifier
n4:46504939 n10:DB02816 n11:FDT n13:21158799
n5:IUPAC-Name
n6:271B5B22-363D-11E5-9242-09173F13E4C5
n5:InChI
n6:271B5B28-363D-11E5-9242-09173F13E4C5
n5:Molecular-Formula
n6:271B5B27-363D-11E5-9242-09173F13E4C5
n5:Molecular-Weight
n6:271B5B24-363D-11E5-9242-09173F13E4C5
n5:Monoisotopic-Weight
n6:271B5B25-363D-11E5-9242-09173F13E4C5
n5:SMILES
n6:271B5B26-363D-11E5-9242-09173F13E4C5
n5:Water-Solubility
n6:271B5B20-363D-11E5-9242-09173F13E4C5
n5:logP
n6:271B5B1E-363D-11E5-9242-09173F13E4C5 n6:271B5B21-363D-11E5-9242-09173F13E4C5
n5:logS
n6:271B5B1F-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Acceptor-Count
n6:271B5B2E-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Donor-Count
n6:271B5B2F-363D-11E5-9242-09173F13E4C5
n5:InChIKey
n6:271B5B29-363D-11E5-9242-09173F13E4C5
n5:Polar-Surface-Area--PSA-
n6:271B5B2A-363D-11E5-9242-09173F13E4C5
n5:Polarizability
n6:271B5B2C-363D-11E5-9242-09173F13E4C5
n5:Refractivity
n6:271B5B2B-363D-11E5-9242-09173F13E4C5
n5:Rotatable-Bond-Count
n6:271B5B2D-363D-11E5-9242-09173F13E4C5
n5:Bioavailability
n6:271B5B34-363D-11E5-9242-09173F13E4C5
n5:Ghose-Filter
n6:271B5B36-363D-11E5-9242-09173F13E4C5
n5:MDDR-Like-Rule
n6:271B5B37-363D-11E5-9242-09173F13E4C5
n5:Number-of-Rings
n6:271B5B33-363D-11E5-9242-09173F13E4C5
n5:Physiological-Charge
n6:271B5B32-363D-11E5-9242-09173F13E4C5
n5:Rule-of-Five
n6:271B5B35-363D-11E5-9242-09173F13E4C5
n5:Traditional-IUPAC-Name
n6:271B5B23-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-acidic-
n6:271B5B30-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-basic-
n6:271B5B31-363D-11E5-9242-09173F13E4C5